Global Myomectomy Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
-
17108
-
May 2023
-
189
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
“Global Myomectomy Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global myomectomy market has been segmented on the basis of myomectomy type, myomectomy product, as well as regions and countries.
Overview:
Myomectomy, also known as fibroidectomy, refers to the surgical removal of uterine leiomyomas, also known as fibroids. In contrast to a hysterectomy, the uterus remains preserved and the woman retains her reproductive potential.
Dynamics:
The growing number of individuals suffering from uterine fibroids and other related disorders, as well as the incorporation of technological advancements to improve patient safety are some of the primary factors that are expected to have a significant impact on the revenue growth of the global myomectomy market in the foreseeable future.
Moreover, the increasing popularity of minimally invasive and non-invasive myomectomy procedures such as laparoscopic and robot-assisted myomectomy surgeries, etc., due to their respective benefits is another major factor that is slated to have a positive influence on the future market growth of the global myomectomy industry.
However, in light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global myomectomy industry is no different, and this factor is expected to have a detrimental impact on market growth in the years to come. Furthermore, a growing number of individuals are electing to postpone surgeries, if possible, as a precautionary measure to avoid being admitted in a medical facility at this given time. This is a factor that could also hamper potential growth opportunities for the global myomectomy industry.
Nonetheless, the increasing number of initiatives being implemented by government and non-profit organizations in conjunction various medical facilities to improve the treatment or assistance offered is a factor that is expected to exponentially influence the revenue growth of the global myomectomy market over the next 10 years.
Segmentation of the global myomectomy market is as follows:
In terms of type, the abdominal myomectomy segment accounted for the maximum number of revenue shares of the global myomectomy market in 2020, and is slated to register a considerable rate of revenue growth in the coming years. This can be accredited to the fact that this is the most performed type of procedure and is a proven permanent form of treatment. However, the laparoscopic myomectomy segment is anticipated to index the highest CAGR over the forecast period.
On the basis of product, the ‘others’ segment constituted the majority number of revenue shares of the global myomectomy market in 2020, and is expected to register a high CAGR over the forecast period. This can be accredited to the various benefits this segment offers such as, same-day procedures, fast recovery, as well as being less invasive procedures.
Regional Segmentation and Analysis:
North America accounted for the highest number of revenue shares of the global myomectomy market in 2020. This can be attributed to a greater number of women reporting uterine fibroid disorders, better reimbursement facilities, increasing government initiatives, as well as the large presence of key industry players and a well-established healthcare infrastructure in this region. However, the markets in the Asia Pacific region are expected to register the highest CAGR over the next decade.
Segmentation of the Global Myomectomy Market:
Segmentation by Myomectomy Type:
- Abdominal Myomectomy
- Hysteroscopic Myomectomy
- Laparoscopic Myomectomy
Segmentation by Myomectomy Product:
- Laparoscopic Power Morcellators
- Harmonic Scalpel
- Laparoscopic Sealer
- Others
Segmentation by Regions:
- North America
- Europe
- APAC
- South America
- MEA
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- Medtronic Plc
- Stryker Corporation
- ConMed Corporation
- INSIGHTEC Ltd.
- CooperSurgical Inc.
- Hologic Inc.
- Intuitive Surgical Inc.
- Karl Storz SE & Co. KG
- B. Braun Melsungen AG
Our Clients
View Our Licence Options
